On January 16, 2024, Noctrix Health, Inc. closed the transaction. The transaction is led by new investor, Sectoral Asset Management Inc. The transaction included participation from new investors, Angelini Ventures, ResMed Inc., Asahi Kasei Corporate Venture Capital, and returning investors, OrbiMed Advisors LLC, and Treo Ventures, LLC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
206 USD | -0.41% |
|
+7.08% | +19.72% |
07-01 | ResMed Inc.(NYSE:RMD) added to Russell 1000 Dynamic Index | CI |
07-01 | ResMed Inc.(NYSE:RMD) added to Russell Midcap Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.72% | 30.38B | |
+4.57% | 212B | |
+8.61% | 187B | |
+26.34% | 155B | |
+33.90% | 115B | |
+2.17% | 65.5B | |
+14.50% | 52.87B | |
-3.30% | 45.25B | |
-3.98% | 39.7B | |
+6.66% | 37.72B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- Noctrix Health, Inc. announced that it has received $39.999991 million in funding from Sectoral Asset Management Inc., Angelini Ventures, ResMed Inc., Asahi Kasei Corporate Venture Capital, OrbiMed Advisors LLC, Treo Ventures, LLC